Latest Communications

07 July 2010
MonoSol Rx Announces FDA Approval of Zuplenz® Oral Soluble Film for Treatment of Nausea and Vomiting

15 June 2010
APR Applied Pharma Research s.a. of Switzerland launches its new corporate website and announces key strategic changes in its Business Model to better compete in the rapidly changing Healthcare industry

09 June 2010
MonoSol Rx and APR Applied Pharma Research s.a. Expand Joint Collaboration Agreement to develop and commercialize film formulations of prescription products


topical

Topical

APR has a long experience in topical pharmaceutical, medical device and dermo cosmetics formulations: a dynamic approach coupled with a solid background enables APR to offer the best and the most complete support starting from galenic phase to a complete Dossier ready for filling or Notification purpose.
APR has experience both on conventional and on modified release formulations and its galenic approach can range through different pharmaceutical forms such as gels, creams, ointments, spray, Hidro-gel and Matrix Patch.




Search results